-

CDL·Issue 18
Diabetes and liver disease are common chronic diseases in China. They interact with each other in terms of pathogenesis, clinical manifestations, and therapeutic targets, often serving as mutual risk factors. Effective co-management can help reduce the disease burden. To support the development of diabetes and liver disease co-management in China, this journal, in collaboration with…
-

Chinese guidelines on the management of ascites in cirrhosis
In 2023, the Chinese Society of Hepatology of the Chinese Medical Association updated the 2017 guidelines on managing ascites and associated complications in cirrhosis. These revised guidelines, now termed “Guidelines on the Management of Ascites in Cirrhosis,” provide comprehensive recommendations for the diagnosis and treatment of cirrhotic ascites, spontaneous bacterial peritonitis (SBP), and hepatorenal syndrome…
-

2024 CACA Integrated Breast Cancer Conference |Unified Efforts for Comprehensive Care: Multidisciplinary Experts Discuss Breast Cancer Management ——Dr. Jiayi Chen
The Chinese Anti-Cancer Association, adhering to the tenet of “prevention, screening, diagnosis, treatment, and rehabilitation,” has launched the “Chinese Tumor Integrated Diagnosis and Treatment Guidelines.” At the 2024 CACA Integrated Breast Cancer Conference, “Oncology Frontier” invited three authoritative experts from internal medicine, surgery, and radiotherapy—Dr. Man Li from The Second Hospital of Dalian Medical University,…
-

2024 CACA Integrated Breast Cancer Conference |Unified Efforts for Comprehensive Care: Multidisciplinary Experts Discuss Breast Cancer Management ——Dr. Man Li
The Chinese Anti-Cancer Association, adhering to the tenet of “prevention, screening, diagnosis, treatment, and rehabilitation,” has launched the “Chinese Tumor Integrated Diagnosis and Treatment Guidelines.” At the 2024 CACA Integrated Breast Cancer Conference, “Oncology Frontier” invited three authoritative experts from internal medicine, surgery, and radiotherapy—Dr. Man Li from The Second Hospital of Dalian Medical University,…
-

2024 CACA Integrated Breast Cancer Conference |Unified Efforts for Comprehensive Care: Multidisciplinary Experts Discuss Breast Cancer Management ——Dr. Yingying Xu
The Chinese Anti-Cancer Association, adhering to the tenet of “prevention, screening, diagnosis, treatment, and rehabilitation,” has launched the “Chinese Tumor Integrated Diagnosis and Treatment Guidelines.” At the 2024 CACA Integrated Breast Cancer Conference, “Oncology Frontier” invited three authoritative experts from internal medicine, surgery, and radiotherapy—Dr. Man Li from The Second Hospital of Dalian Medical University,…
-

The 8th Yunnan Breast Cancer Summit Forum | Dr. Zhaoqing Fan: Overview of HR+/HER2- Breast Cancer Treatment Landscape and Prospects of Immunotherapy in Early-Stage Patients
On July 14, the “8th Yunnan Breast Cancer Summit Forum” was held in Kunming, coinciding with the 40th anniversary of the Yunnan Cancer Hospital. This event, organized by the Yunnan Anti-Cancer Association and the China Medical Education Association, and co-hosted by eight institutions including the Peking University Cancer Hospital Yunnan Branch, Yunnan Cancer Hospital, and…
-

Evaluation of the Efficacy and Safety of Entrectinib Targeted Therapy for ROS1 Fusion Detected in Peripheral Blood
The development of modern oncology has provided multiple breakthrough treatment options for lung cancer, making it one of the fastest-evolving solid tumors. To help clinicians comprehensively grasp the significant advancements in this field, “Oncology Frontier” collaborates with Dr. Hua Zhong and Dr. Baohui Han from the Department of Respiratory and Critical Care Medicine at Shanghai…
-

Professor Yutao Zhan: Monitoring and Prevention of NAFLD-Related Liver Cancer
In recent years, the burden of non-alcoholic fatty liver disease (NAFLD) and liver cancer has become increasingly heavy, with a growing incidence of NAFLD-related hepatocellular carcinoma (HCC). Recently, Professor Yutao Zhan from Beijing Tongren Hospital delivered a fascinating presentation titled “Advances in Research on NAFLD-Related Liver Cancer.” The presentation comprehensively analyzed the prevention and control…